Skip to content
10-Q

Quarterly Report

Apotheca Biosciences, Inc.

0001079974-18-000674

← back to feed
Filed
Dec 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Dec 17, 2018 114.4M sh
Operating Cash Flow Q3 2019 · Oct 31, 2018 −$149.14K
Cash And Equivalents Q3 2019 · Oct 31, 2018 $168.46K
Cash And Equivalents Q3 2019 · Apr 30, 2018 $0
Cash And Equivalents Q3 2019 · Feb 25, 2018 $0
Stockholders Equity Q3 2019 · Oct 31, 2018 −$520.91K
Stockholders Equity Q3 2019 · Apr 30, 2018 −$32.24K
Total Liabilities Q3 2019 · Oct 31, 2018 $695.37K
Total Liabilities Q3 2019 · Apr 30, 2018 $32.24K
Total Assets Q3 2019 · Oct 31, 2018 $174.46K
Total Assets Q3 2019 · Apr 30, 2018 $0
Sga Expense Q3 2019 · Oct 31, 2018 $110.76K
Sga Expense Q3 2019 · Oct 31, 2018 $127.98K
Net Income Q3 2019 · Oct 31, 2018 −$313.12K
Net Income Q3 2019 · Oct 31, 2018 −$405.34K
Operating Income Q3 2019 · Oct 31, 2018 −$155.76K
Operating Income Q3 2019 · Oct 31, 2018 −$247.98K
Revenue Q3 2019 · Oct 31, 2018 $0
Revenue Q3 2019 · Oct 31, 2018 $0
Current Liabilities Q3 2019 · Mar 26, 2018 $1.3M